Articles by George Koroneos, Online Content & News Editor - Pharmaceutical Executive

ADVERTISEMENT

Articles by George Koroneos, Online Content & News Editor

UCB Teams with PatientsLikeMe to Learn What Patients Want

Jun 17, 2009

In an effort to learn as more about epilepsy sufferers, UCB will implement a social network that allows patients to communicate about their disease state and treatments. Think of it as one giant, online clinical trial.

Sudden Deaths and ADHD Meds Not Necessarily Related

Jun 17, 2009

Feds claim results of study comparing car crash deaths and children on ADHD drugs were not paramount to pulling kids off of ADHD treatments.

WHO Pushes H1N1 Flu to Pandemic State

Jun 11, 2009

The Word Health Organization just bumped the H1N1 influenza to pandemic alert phase 6 (the highest alert level), making it the first worldwide pandemic in 41 years.

Wyeth Winds Up With New Pristiq Campaign

Jun 10, 2009

What do you do when you are introducing a new drug in an already crowded category? Wyeth queried depression sufferers to find out what they want to see in a drug ad before launching its new DTC campaign for Pristiq.

GSK Teams with Shenzhen Neptunus for Chinese Vaccines

Jun 10, 2009

GlaxoSmithKline is expanding its influenza vaccine efforts through a joint R&D alliance with Shenzhen Neptunus. The goal: to tap the world’s biggest market and attempt to deliver flu shots to more than a billion people.

FDA Launches Transparency Task Force

Jun 3, 2009

The feds green lit a task force charged with easing the flow of communication between FDA, pharma companies, and the general public. While the team is being billed as a task force for transparency, it?s still unclear what is being revealed.

GSK Signs Deal with Concert Pharma to the Tune of $1 Billion

Jun 3, 2009

GlaxoSmithKline has entered into a collaboration deal with Concert to create drugs using deuterium—“heavy hydrogen”—that can be gathered from seawater and used to alter the way molecules perform in the body.

Amgen and CDC to Spearhead Anti-infection Campaign

May 27, 2009

Cancer patients worry not only about their disease, but also the side effects of the drugs they take to treat it. Now the Centers for Disease Control and Prevention and biologics firm Amgen are partnering on a multi-prong program to get patients to pay attention to another, related, danger: chemo-related infections.

FDA Releases Guidance on Risk in Ads

May 27, 2009

You know those loud soundtracks and distracting visuals during the safety information in your TV ads? Critics have been complaining about them, and new draft guidance from FDA is calling them a "no-no."

ADVERTISEMENT

Click here